CVM Stock Analysis: Buy, Sell, or Hold?
CVM - Cel-Sci Corporation
$1.63
0.02 (1.43%)
▲
5d:
+11.86%
30d:
+43.25%
90d:
+10.34%
WAIT
LOW Confidence
Analysis Updated: Aug 26, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When CVM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: CVM shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: CVM shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: CVM is currently trading at $1.63, which is considered extended relative to its 30-day fair value range of $1.23 to $1.58.
Technical Outlook: Technically, CVM is in a strong uptrend. Immediate support is located at $1.34, while resistance sits at $1.70.
Market Sentiment: CVM scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.50 (+676.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CVM is in a strong uptrend. Immediate support is located at $1.34, while resistance sits at $1.70.
Market Sentiment: CVM scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.50 (+676.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.23 -
$1.58
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
26.3%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 676.4% below Wall St target ($12.50)
- WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.23 -
$1.58
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.34
Resistance Level
$1.70
Current Trend
Strong Uptrend
Technical data as of
Aug 26, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.25
Wall Street Target
$12.50
(+676.4%)
Revenue Growth (YoY)
-62.7%
Share & Embed Analysis
Last updated: August 27, 2026 1:04 PM ET
Data refreshes hourly during market hours. Next update: 2:04 PM
Data refreshes hourly during market hours. Next update: 2:04 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CVM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 55 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 52 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 56 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 40 HOLD |
